Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T14:16:34.797Z.
Calculation as of: 2026-10-06T14:16:34.797Z.
Quote observation: 2026-10-06T14:10:51.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
PE RATIO
N/A
Market Cap
$3.39M
PE Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eocene Ltd. (EOCN) | $3.59M | N/A | N/A | N/A | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.56M | N/A | N/A | N/A | N/A |
| Moolec Science S.A. (MLEC)vs › | $3.54M | N/A | N/A | N/A | N/A |
| Evogene Ltd. (EVGN)vs › | $3.52M | N/A | N/A | N/A | N/A |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.39M | N/A | N/A | N/A | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.38M | N/A | N/A | N/A | N/A |
| IceCure Medical Ltd (ICCM)vs › | $3.33M | N/A | N/A | N/A | N/A |
| MBody AI Ltd. (MBAI)vs › | $3.17M | N/A | N/A | N/A | N/A |
| Aptevo Therapeutics Inc. (APVO)vs › | $4.02M | N/A | 1.58 | 1.58 | 1.58 |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.11M | N/A | N/A | N/A | N/A |
Trailing P/E
N/A
Forward P/E
N/A
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
